Is this really the current status of small bowel transplantation in the UK? [9]

Gut

Volumn 55, Issue 6, 2006, Pages 903-

  Gupte, G L ^a   Beath, S V ^a   Millar, A J W ^a   Kelly, D A ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; MONOCLONAL ANTIBODY; RITUXIMAB;

ADOPTIVE IMMUNOTHERAPY; CHEMOTHERAPY; EARLY DIAGNOSIS; ENTERITIS; EPSTEIN BARR VIRUS; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE GRAFT; INTESTINE RESECTION; INTESTINE TRANSPLANTATION; LETTER; LIVER GRAFT; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTOZOAL INFECTION; RISK FACTOR; UNITED KINGDOM; VIRUS INFECTION;

EID: 33646764177     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.092601     Document Type: Letter

References (4)

1. de Ville DG, Mitchell A, Moyer AD, et al. En block combined reduced-liver and small bowel transplants: from large donors to small children. Transplantation 2000;69:555-9.
2. Ziring D, Tran R, Edelstein S, et al. Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation 2005;79:702-9.
3. Grant D, Abu-Elmagd K, Reves J, et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 2005;241:607-13.
4. Green M, Webber S. Posttransplantation lymphoproliferative disorders. Pediatr Clin North Am 2003;50:1471-91.